Abbott Laboratories v. Sandoz, Inc.’s Empirical Analysis
2007
Citation profile
1 federal appellate ·
Relationships
Applies 35 U.S.C. § 283
Relies on Warner-Jenkinson Company Inc v. Hilton Davis Chemical Co · Markman v. Westview Instruments, Inc. · Cybor Corporation v. Fas Technologies, Inc., and Fastar Ltd., Defendants-Cross · Genentech, Inc. v. Novo Nordisk, A/S · Amazoncom Inc v. Barnesandnoblecom Inc Barnesandnoblecom Llc
Most-quoted passages
The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 2 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.
“2. Crystalline 7-[2-(2-a minothiazol-4-yl)-2-hydroxyiminoacetamido] -3-vinyl-3-cephem-4-carboxylic acid (syn isomer) which is obtainable by acidifying a solution containing 7-[2-(2-aminothia-zol-4~yl)-2-hydroxyiminoacetamido]-3vinyl -3-cephem-4-carboxylie acid (syn isomer) at room temperature or under warming. 5. Crystalline 7-[2-(2~aminothiazol-4-yl)-2-hydroxyiminoacetamido]-3-vinyl - 3-cephem-4-carboxylic acid (syn isomer) which is obtainable by dissolving 7-[2-(2-aminothiazol-4-yl)-2 -hydroxyiminoacetamido]-3-vinyl-3-cephem-4-carboxylic acid (syn isomer) in an alcohol, continuing to stir the solution slowly under warming, then cooling the solution to room temperature and allowing the solution to stand.”
1 later decision quote this exact passage · from the majority“1. Crystalline 7-[2-(2-a minothiazol-4-yl)-2-hydroxyiminoacetamido]-3-vinyl3-cephem.-4-carboxylic acid (syn isomer) which shows the peaks at the diffraction angles shown in the following table in its powder X-ray diffraction pattern: diffraction angle (°) about 14.7° about 17.8° about 21.5° about 22.0° about 23.4° about 24.5° about 28.1°”
1 later decision quote this exact passage · from the majority
How this case has been treated — in progress
Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.